AIRSUPRA® (albuterol/budesonide) US prescribing information updated to reflect the statistically significant severe exacerbation risk reduction in patients with mild asthma compared with albuterol ...

The FDA has updated the prescribing information for Airsupra, a fixed dose of albuterol and budesonide, to include that it ...

Airsupra is a pressurized metered dose inhaler containing a combination of albuterol, a SABA, and budesonide, an ICS.

Airsupra U.S. prescribing information now includes clinically meaningful evidence from the BATURA study in patients with mild ...

Learn strategies to maximize lung function with ALS, including breathing exercises, ventilation options, and lifestyle adjustments.

With more than 50 million redeemed miles under her belt, Becky Pokora is a rewards travel expert. She's been writing about credit cards and reward travel since 2011 with articles on Forbes Advisor, ...

The FDA approved the use of pembrolizumab (Keytruda; Merck) and berahyaluronidase alfa-pmph (Keytruda Qlex; Merck) for use in patients 12 years and older with solid tumor indications approved for the ...

In a now-completed clinical trial, the stem cell therapy Neuronata-R was found to benefit ALS patients with slower disease ...

The FDA has approved a new injectable version of cancer drug Keytruda as Merck seeks to protect its market dominance.  Here are five things to know: ...

AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus ...